Artikel ; Online: Steroidal alkaloid solanidine impedes hypoxia-driven ATM phosphorylation to switch on anti-angiogenesis in lung adenocarcinoma.
Phytomedicine : international journal of phytotherapy and phytopharmacology
2023 Band 119, Seite(n) 154981
Abstract: Purpose: The declined oxygen tension in the cancer cell leads to the hypoxic adaptive response and favors establishment of tumor micro environment [TEM]. The complex TME consists of interwoven hypoxic HIF-1α and DNA damage repair ATM signaling. The ATM/ ... ...
Abstract | Purpose: The declined oxygen tension in the cancer cell leads to the hypoxic adaptive response and favors establishment of tumor micro environment [TEM]. The complex TME consists of interwoven hypoxic HIF-1α and DNA damage repair ATM signaling. The ATM/HIF-1α phosphorylation switch on angiogenesis and abort apoptosis. Targeting this signaling nexus would be a novel therapeutic strategy for the treatment of cancer. Background: Steroidal alkaloid solanidine is known for varied pharmacological role but with less molecular evidences. Our earlier findings on solanidine proven its anti-neoplastic activity by inducing apoptosis in lung cancer. In continued research, efforts have been made to establish the underlying molecular signaling in induction of DNA damage in prevailing hypoxic TME. Methods: The solanidine induced DNA damage was assessed trough alkali COMET assay; signaling nexus and gene expression profile analysis through IB, qRT-PCR, Gelatin Zymography, IHC, IF and ELISA. Pathophysiological modulations assessed through tube formation, migration, invasion assays. Anti-angiogenic studies through CAM, rat aorta, matrigel assays and corneal neovascularization assay. Anti-tumor activity through in-vivo DLA ascites tumor model and LLC model. Results: The results postulates, inhibition of hypoxia driven DDR proteins pATM |
---|---|
Mesh-Begriff(e) | Rats ; Animals ; Phosphorylation ; Antineoplastic Agents/therapeutic use ; Hypoxia/drug therapy ; Alkaloids/pharmacology ; Adenocarcinoma of Lung/drug therapy ; Lung Neoplasms/drug therapy ; Hypoxia-Inducible Factor 1, alpha Subunit ; Neovascularization, Pathologic/drug therapy ; Cell Line, Tumor ; Tumor Microenvironment |
Chemische Substanzen | solanidine (W7801OHM8B) ; Antineoplastic Agents ; Alkaloids ; Hypoxia-Inducible Factor 1, alpha Subunit |
Sprache | Englisch |
Erscheinungsdatum | 2023-07-18 |
Erscheinungsland | Germany |
Dokumenttyp | Journal Article |
ZDB-ID | 1205240-1 |
ISSN | 1618-095X ; 0944-7113 |
ISSN (online) | 1618-095X |
ISSN | 0944-7113 |
DOI | 10.1016/j.phymed.2023.154981 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 4115: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.